Neurology · Hypertensive Emergency
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Hypertensive encephalopathy is a hypertensive emergency defined by severe hypertension (typically >180/120 mmHg) accompanied by acute end-organ damage manifesting as altered mental status, seizures, or focal neurologic deficits.
The underlying pathophysiology involves the failure of cerebral autoregulation, leading to breakthrough cerebral vasodilation, hyperperfusion, and cerebral edema.
Funduscopic examination is mandatory and typically reveals papilledema, flame-shaped hemorrhages, or cotton-wool spots indicating malignant hypertension.
The first-line treatment is the immediate initiation of intravenous antihypertensive therapy using agents like nicardipine, labetalol, or clevidipine.
Blood pressure reduction must be gradual to prevent cerebral hypoperfusion and ischemic stroke, with a target of reducing the mean arterial pressure (MAP) by no more than 10-20% in the first hour.
Neuroimaging (typically non-contrast CT head) is required to exclude intracranial hemorrhage, ischemic stroke, or mass lesions that mimic the clinical presentation.
Posterior Reversible Encephalopathy Syndrome (PRES) is a closely related clinical-radiologic entity characterized by vasogenic edema in the parieto-occipital regions on MRI.
Vignette unlocked
A 54-year-old male with a history of poorly controlled hypertension presents to the emergency department with a severe, throbbing headache, nausea, and confusion. On physical exam, his blood pressure is 210/130 mmHg. Neurologic examination reveals bilateral papilledema and disorientation to time and place, but no focal motor deficits. A non-contrast CT head is performed and shows no evidence of intracranial hemorrhage or mass effect.
What is the most appropriate initial management for this patient?
Intravenous nicardipine or labetalol with a goal of reducing MAP by 10-20% in the first hour.
The patient presents with signs of hypertensive emergency (hypertensive encephalopathy); the priority is controlled, gradual reduction of blood pressure using IV agents to prevent end-organ ischemia.
Full handout
High yield triage
Etiology / Epidemiology
Occurs in hypertensive emergency when autoregulation fails. Common in patients with uncontrolled hypertension or abrupt medication cessation.
Clinical Manifestations
Presents with severe headache, altered mental status, and papilledema. Seizures and focal deficits are common.
Diagnosis
Diagnosis of exclusion. Brain MRI is the gold standard to rule out stroke. BP >180/120 mmHg with end-organ damage.
Treatment
Immediate reduction of MAP by 10-20% in first hour. Nicardipine or Labetalol are first-line. Avoid rapid BP drops.
Prognosis
Reversible if treated promptly. Permanent neurological deficits occur if ischemia persists.
Full handout
Epidemiology & Etiology
Primarily affects patients with chronic hypertension who experience a sudden, severe spike in systemic pressure. Often triggered by non-compliance with antihypertensive therapy or secondary causes like pheochromocytoma. It is a form of hypertensive emergency requiring immediate ICU admission.
Pertinent Anatomy
The Circle of Willis and cerebral arterioles are the primary sites of autoregulatory failure. Breakdown of the blood-brain barrier leads to cerebral edema, specifically affecting the posterior regions of the brain.
Pathophysiology
Systemic pressure exceeds the upper limit of cerebral autoregulation, causing forced vasodilation. This leads to hyperperfusion, capillary leakage, and cerebral edema. The resulting breakthrough hyperperfusion causes the classic neurological symptoms observed in the patient.
Clinical Manifestations
Patients present with severe headache, nausea, vomiting, and confusion. Look for papilledema and hypertensive retinopathy (flame hemorrhages, exudates) on funduscopic exam, which support elevated intracranial pressure. Seizures and focal neurological deficits are red flags indicating imminent cerebral infarction.
Diagnosis
Diagnosis is clinical, supported by BP >180/120 mmHg and evidence of end-organ damage. Brain MRI is the gold standard to differentiate from ischemic or hemorrhagic stroke. Lumbar puncture is rarely indicated but would show elevated opening pressure.
Treatment
Goal is a controlled reduction of MAP by 10-20% in the first hour, then 5-15% over the next 23 hours. Nicardipine or Labetalol are the preferred first-line agents. Avoid rapid BP reduction as this can precipitate cerebral ischemia. Use arterial line monitoring for titratable IV infusions.
Prognosis
Prognosis is excellent if mean arterial pressure is lowered safely and gradually. Failure to treat leads to cerebral infarction, permanent cognitive impairment, or death. Requires ICU admission for continuous hemodynamic monitoring.
Differential Diagnosis
Ischemic Stroke: focal deficits usually present without severe BP elevation
Hemorrhagic Stroke: CT head shows acute hyperdensity
Metabolic Encephalopathy: normal BP and specific lab abnormalities
Eclampsia: occurs in pregnancy with proteinuria
Meningitis: presents with nuchal rigidity and fever